Advertisement

Current Diabetes Reports

, 19:119 | Cite as

Diabetes in the Workplace: the Hazards of Hypoglycemia

  • Robert M. GerboEmail author
  • Chuan Fang Jin
  • Karen Clark
Lifestyle Management to Reduce Diabetes/Cardiovascular Risk (B Conway and H Keenan, Section Editors)
  • 16 Downloads
Part of the following topical collections:
  1. Topical Collection on Lifestyle Management to Reduce Diabetes/Cardiovascular Risk

Abstract

Purpose of Review

The effects of hypoglycemia can result in injury, including at work. Our goal was to review the recent medical literature regarding hypoglycemia and occupational injuries and provide guidance to clinicians asked to render opinions regarding fitness for work duties in individuals with diabetes.

Recent Findings

Recent studies contain conflicting conclusions regarding the occupational risks posed by workers with diabetes. However, the US Federal Motor Carrier Safety Administration concluded there was sufficient evidence to change the rule that previously disqualified commercial drivers with insulin-treated diabetes.

Summary

Blanket employment policies that disqualify workers with diabetes are unnecessary in many occupational fields. In assessing occupational risks and fitness for duty in workers with diabetes, it is important to perform an individualized assessment of the worker and consider the risk factors for hypoglycemia, information from the treating clinician, essential functions of the job, and, if needed, availability of reasonable accommodations.

Keywords

Occupational hazards Diabetes Hypoglycemia Workplace accommodations 

Notes

Authors’ Contributions

R.M.G. is the corresponding author for the manuscript. All authors contributed to the design and drafting of the paper and reviewed and approved the manuscript for scholarly content.

Funding

R.M.G., C.F.J., and K.C. are supported by the University Health Associates and West Virginia University. The authors were fully responsible for all content and editorial decisions and were involved at all stages of manuscript development and have approved the final version.

Compliance with Ethical Standards

Conflict of Interest

Robert M. Gerbo, Chuan Fang Jin, and Karen Clark declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. 1.
    Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2017. Atlanta, GA: Centers for Disease Control and Prevention, U.S. Dept of Health and Human Services; 2017. https://www.cdc.gov/diabetes/data/statistics/statistics-report.html. Accessed June 18, 2019.
  2. 2.
    Rossi MC, Niculucci A, Ozzello A, Gentile S, Aglialora A, et al, on behalf of the HYPOS-1 Study Group of AMD. Impact of severe and symptomatic hypoglycemia on quality of life and fear of hypoglycemia in type 1 and type 2 diabetes. Results of the Hypos-1 observational study. Nutrition, Metabolism and Cardiovasc Diseases 2019 (in press).  https://doi.org/10.1016/j.numecd.2019.04.009, 29, 736, 743.CrossRefGoogle Scholar
  3. 3.
    El-Menyar A, Mekkodathil A, Al-Thani H. Traumatic injuries in patients with diabetes mellitus. J Emerg Trauma Shock. 2016;9(2):64–72.  https://doi.org/10.4103/0974-2700.179461.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Pedersen-Bjergaard U, Thorsteinsson B. Reporting severe hypoglycemia in type 1 diabetes: facts and pitfalls. Curr Diab Rep. 2017;17:131.  https://doi.org/10.1007/s11892-017-0965-1.
  5. 5.
    Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care. 2013;36:1384–95.  https://doi.org/10.2337/dc12-2480.CrossRefGoogle Scholar
  6. 6.
    Fulcher G, Singer J, Castañeda R, Fraige Filho F, Maffei L, Snyman J, et al. The psychological and financial impacts of non-severe hypoglycemic events on people with diabetes: two international surveys. J Med Econ. 2014;17:751–61.  https://doi.org/10.3111/13696998.2014.946992.CrossRefGoogle Scholar
  7. 7.
    Kubo J, Goldstein BA, Cantley LF, Tessier-Sherman B, Galusha D, Slade MD, et al. Contribution of health status and prevalent chronic disease to individual risk for workplace injury in the manufacturing environment. Occup Environ Med. 2014;71:159–66.  https://doi.org/10.1136/oemed-2013-101653.CrossRefGoogle Scholar
  8. 8.
    Kouvonen A, Kivimäki M, Pentti J, Aalto V, Oksanen T, Virtanen M, et al. Diabetes and risk of occupational injury: a cohort study. Diabetic Med. 2017;34:1629–36. 10.111.dme.13423.  https://doi.org/10.1111/dme.13423 CrossRefGoogle Scholar
  9. 9.
    Li AKC, Nowrouzi-Kia B. Impact of diabetes mellitus on occupational health outcomes in Canada. Int J Occup Environ Med. 2017;8:96–108.  https://doi.org/10.15171/ijoem.2017.992.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Palmer KT, D’Angelo S, Harris EC, Linaker C, Coggan D. Epilepsy, diabetes mellitus and accidental injury at work. Occup Med. 2014;64:448–53.  https://doi.org/10.1093/occmed/kqu079.CrossRefGoogle Scholar
  11. 11.
    Sprince NL, Pospisil S, Peek-Asa C, Whitten PS, Zwerling C. Occupational injuries among workers with diabetes: the National Health Interview Survey, 1997-2005. J Occup Environ Med. 2008;50(7):804–8.  https://doi.org/10.1097/JOM.0b013e318168efcf.CrossRefPubMedGoogle Scholar
  12. 12.
    Nathan DM, the DCCT/EDIC Research Group. The Diabetes and Complications Trial/Epidemiology of Diabetes Interventions and Complications study at 30 years: overview. Diabetes Care. 2014;37:9–16.  https://doi.org/10.2337/dc13-2112.CrossRefPubMedGoogle Scholar
  13. 13.
    Federal Motor Carrier Administration. Qualification of drivers; diabetes standard. Federal Register. https://www.federalregister.gov/documents/2015/05/04/2015-09993/qualifications-of-drivers-diabetes-standard. Accessed June 22, 2019.
  14. 14.
    49 CFR Part 391. Qualifications of drivers; diabetes standard. https://www.govinfo.gov/content/pkg/FR-2018-09-19/pdf/2018-20161.pdf. Accessed June 20, 2019.
  15. 15.
    International Hypoglycaemia Study Group. Glucose concentrations of less than 3.0 mmol/L (54 mg/dL) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2017;40:155–7.  https://doi.org/10.2337/dc16-2215.CrossRefGoogle Scholar
  16. 16.
    Cryer PE. Mechanisms of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med. 2013;369:362–72.  https://doi.org/10.1056/NEJMra1215228.CrossRefPubMedGoogle Scholar
  17. 17.
    American Diabetes Association. Signs and symptoms of low blood glucose (happen quickly). http://www.diabetes.org/living-with-diabetes/treatment-and-care/blood-glucose-control/hypoglycemia-low-blood.html. Accessed June 20, 2019.
  18. 18.
    •• American Diabetes Association. Glycemic targets: standards of medical care in diabetes−2019. Diabetes Care. 2019;42(Supplement 1):S61–70.  https://doi.org/10.2337/dc19-S006. The ADA Professional Practice Committee (a multidisciplinary panel of experts) updates the Standards of Medical Care in Diabetes regularly and provides healthcare professionals with a comprehensive, evidence-based reference.
  19. 19.
    Agiostratidou G, Anhalt H, Ball D, Blonde L, Gourgari E, Harriman KN, et al. Standardizing clinically meaningful outcome measures beyond HbA1c for type 1 diabetes: a consensus report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange. Diabetes Care. 2017;40:1622–30.  https://doi.org/10.2337/dc17-1624.CrossRefGoogle Scholar
  20. 20.
    Douros A, Yin H, Yu OHY, Filion KB, Azoulay L, Suissa S. Pharmacologic differences of sulfonylureas and the risk of adverse cardiovascular and hypoglycemic events. Diabetes Care. Nov 2017;40(11):1506–13.  https://doi.org/10.2337/dc17-0595.CrossRefPubMedGoogle Scholar
  21. 21.
    Pathak RD, Schroeder EB, Seaquist ER, Zeng C, Lafata JE, Thomas A, et al. For the SUPREME-DM Study Group. Severe hypoglycemia requiring medical intervention in a large cohort of adults with diabetes receiving care in U.S. integrated health care delivery systems: 2005-2011. Diabetes Care. 2016;39:363–70.  https://doi.org/10.2337/dc15-0858. CrossRefGoogle Scholar
  22. 22.
    Davis TME, Bruce DG, Finn J, Curtis BH, Barraclough H, Davis WA. Temporal changes in the incidence and predictors of severe hypoglycaemia in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Obes Metab. 2019;21:648–57.  https://doi.org/10.1111/dom.13568.CrossRefPubMedGoogle Scholar
  23. 23.
    Giorda CB, Ozzello A, Gentile S, Aglialoro A, Chiambretti A, Baccetti F, et al. Incidence and risk factors for severe and symptomatic hypoglycemia in type 1 diabetes. Results of the HYPOS-1 study. Acta Diabetol. 2015;52:845–53.  https://doi.org/10.1007/s00592-015-0713-4.CrossRefGoogle Scholar
  24. 24.
    Strandberg AY, Khanfir H, Mäkimattila S, Saukkonen T, Strandberg TE, Hoti F. Insulins NPH, glargine, and detemir, and risk of severe hypoglycemia among working-age adults. Ann Med. 2017;49:357–64.  https://doi.org/10.1080/07853890.2016.1278302.CrossRefPubMedGoogle Scholar
  25. 25.
    Shapiro AR. FDA approval of nonadjunctive use of continuous glucose monitors for insulin dosing: a potentially risky decision. JAMA. 2017;318(16):1541–2.  https://doi.org/10.1001/jama.2017.12075.CrossRefPubMedGoogle Scholar
  26. 26.
    American Diabetes Association. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Supplement 1):S90–S102.  https://doi.org/10.2337/dc19-S009.
  27. 27.
    •• American Diabetes Association. Diabetes and Employment Diabetes Care 2014;37(Supplement 1): S112- S117. doi: 10.2337/dc14-S112. This reference includes guidelines for evaluating workers and job applicants with diabetes. Google Scholar
  28. 28.
    Dimmick BL, Douglas D. Reasonable accommodations for diabetes management in the workplace. http://main.diabetes.org/dorg/PDFs/Advocacy/Discrimination/litigation-materials/reasonable-accommodations-for-diabetes-management-in-the-workplace.pdf. Accessed June 20, 2019.
  29. 29.
  30. 30.
    US Equal Employment Opportunity Commission. https://www.eeoc.gov/laws/types/diabetes.cfm. Accessed June 20, 2019.
  31. 31.
    Insulin-treated diabetes mellitus assessment form, MCSA-5870. https://www.fmcsa.dot.gov/regulations/medical/insulin-treated-diabetes-mellitus-assessment-form-mcsa-5870. Accessed June 20, 2019.
  32. 32.
    Brum MCB, Piana MD, Filho FFD. What conditions should be assessed in evaluating individuals who work in confined spaces? JOEM. 2016;58:152–3.  https://doi.org/10.1097/JOM.00000000000000684.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Robert M. Gerbo
    • 1
    Email author
  • Chuan Fang Jin
    • 1
  • Karen Clark
    • 2
  1. 1.Department of Occupational and Environmental Sciences, Section of Occupational MedicineWest Virginia University School of Public HealthMorgantownUSA
  2. 2.Department of Medicine, Section of General Internal MedicineWest Virginia University School of MedicineMorgantownUSA

Personalised recommendations